This technology automatically detects endotracheal tube (ETT) position and sends real-time alerts. Cross-hospital validation confirms clinical benefits. It targets global markets including Taiwan, the U.S., Asia-Pacific, and Europe, with annual potential worth billions of NT dollars. The business model focuses on licensing and co-development with medical software and ICU integrators, leveraging existing platforms for rapid growth and stable profits, offering strong commercialization prospects.

This technology integrates the YOLO algorithm model with chest X-ray imaging to automatically detect endotracheal tube (ETT) position and provide alerts. It overcomes the limitations of traditional manual interpretation and external markings by offering real-time, objective, and high-accuracy decision support. With cross-hospital validation showing accuracy of over 90%, the system demonstrates strong potential for clinical application, commercialization, and expansion to other medical utilities.

This technology automatically detects endotracheal tube (ETT) position and sends real-time alerts. Cross-hospital validation confirms clinical benefits. It targets global markets including Taiwan, the U.S., Asia-Pacific, and Europe, with annual potential worth billions of NT dollars. The business model focuses on licensing and co-development with medical software and ICU integrators, leveraging existing platforms for rapid growth and stable profits, offering strong commercialization prospects.